Comment on the future of wholesaling for C & D

23 January 2008

Copy should be attributed to Mark James, group managing director for AAH Pharmaceuticals 

The key challenge facing wholesalers/agents is to become even more focused on delivering the needs and expectations of suppliers and dispensing customers at a time when those needs are changing significantly.

AAH is fully prepared to meet that challenge.

For example, the shift from dispensing to the provision of patient services will continue. For AAH that means ensuring we have the best range of professional services and supports which pharmacy needs in order to deliver patient services, both now and in the future.

The one-size-fits-all traditional wholesale model has gone. At AAH, our commitment is to provide suppliers with bespoke innovative solutions which meet their particular individual needs: for some that will be a wholesale model and for others agency agreements.

What differentiates AAH is our partnership approach which allows suppliers to maximise their relationship with us, but which also helps them establish stronger and mutually beneficial relationships with dispensing customers.

Through LINK AAH will remain a key supplier of IT solutions to our customers. Despite the delays there can be little doubt about the direction of travel. ETP will come and e-solutions will increasingly underpin patient services such as MURs and MAS.

Finally, we will no doubt see further scrutiny of health budgets, including the cost of drugs. The reality is that all aspects of the supply chain are inextricably linked: if you take money out of one aspect it impacts upon the others. If suppliers or dispensers are squeezed then wholesalers/agents feel the impact of that as well.

 

For further press information, please contact:

Dean Enon

Gravitas Public Relations, 7 Imperial Square, Cheltenham, GLOS GL50 1QB

Tel: 01242 211000

E: Dean@gravitaspr.co.uk